Related Blog Entries

• Safety Alert Issued for Prisma Renal Intensive Care System
• Cleveland Clinic suggests ban on Natrecor
• Natrecor safety study still not underway
• Natrecor Safety Study announced
• Link between Natrecor and early deaths
• Natrecor worsens kidney risk
• Public Health Advisory Issued for Crestor highlights risk of serious muscle toxicity
• Trasylol pulled from U.S. market
• FDA Warns of Potential Risks of Exjade
• Gambro to rollout Prisma fix
• FDA’s second safety review of Trasylol to begin
• More than 50 lawsuits filed over Fleet Phospho-soda injuries
• Death of heart bypass surgery patient raised questions about Bayer’s Trasylol
• Novartis’ Exjade could cause kidney failure, death
• Safety of Abbott’s drug TriCor questioned
• NC Hog Farm Quarantined for Melamine Contamination Linked to Pet Food Recall
• Cyanuric Acid found in tissue samples linked to recalled pet feed
• Trasylol raises death risk nearly 50 percent